CAS: 17660-02-5 - Scopolamine -D-Glucuronide
Fórmula:C23H29NO10
InChI:InChI=1/C23H29NO10/c1-24-13-7-11(8-14(24)19-18(13)33-19)32-22(30)12(10-5-3-2-4-6-10)9-31-23-17(27)15(25)16(26)20(34-23)21(28)29/h2-6,11-20,23,25-27H,7-9H2,1H3,(H,28,29)/t11?,12-,13?,14?,15-,16-,17-,18?,19?,20?,23+/m1/s1
- Sinónimos:
- (-)-Scopolamine 9'-glucuronide
- (2S)-3-[[(1a,2,4,5a,7)-9-Methyl-3-oxa-9-azatricyclo[3.3.1.02,4]non-7-yl]oxy]-3-oxo-2-phenylpropyl -D-Glucopyranosiduronic Acid
- Scopolamine O--D-glucuronide
Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
---|---|---|---|---|
Scopolamine O-b-D-glucuronide REF: 7W-GC1628CAS: 17660-02-5 | - - - | A consultar | Mar 07 Ene 25 | |
Scopolamine Glucuronide REF: 4Z-S-016CAS: 17660-02-5 | - - - | A consultar | Lun 13 Ene 25 | |
Scopolamine β-D-Glucuronide REF: TR-S200010CAS: 17660-02-5 | >85% | 1.217,00 €~2.166,00 € | Mar 14 Ene 25 | |
Scopolamine O-b-D-glucuronide REF: 3D-MS09952CAS: 17660-02-5 | Min. 95% | A consultar | Mar 18 Feb 25 |
Ref: 7W-GC1628
Tamaño no definido | A consultar |
Entrega estimada en Estados Unidos, el Martes 7 de Enero de 2025
Ref: 4Z-S-016
10mg | A consultar | ||
25mg | A consultar | ||
50mg | A consultar | ||
100mg | A consultar |
Entrega estimada en Estados Unidos, el Lunes 13 de Enero de 2025
Scopolamine β-D-Glucuronide
Producto controladoCAS:17660-02-5
Stability Hygroscopic Applications A metabolite of Scopolamine. References Shutt, L., et al.: Anaesthesia, 34, 476 …
Fórmula:
C23H29NO10
Pureza:
>85%
Forma y color:
Neat
Peso molecular:
479.48
Ref: TR-S200010
1mg | 1.217,00 € | ||
10mg | 2.166,00 € |
Entrega estimada en Estados Unidos, el Martes 14 de Enero de 2025
Scopolamine O-b-D-glucuronide
CAS:17660-02-5
Scopolamine O-b-D-glucuronide is a methylated derivative of scopolamine. It is an oligosaccharide that is synthesized …
Fórmula:
C23H29NO10
Pureza:
Min. 95%
Peso molecular:
479.48 g/mol
Ref: 3D-MS09952
1mg | A consultar | ||
5mg | A consultar | ||
10mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 18 de Febrero de 2025